✦ LIBER ✦

Use of novel proteosome inhibitors as a therapeutic strategy in lymphomas current experience and emerging concepts

✍ Scribed by Emmanuel Akinola Abayomi; Gerhard Sissolak; Peter Jacobs

Book ID: 116928645
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 125 KB
Volume: 37
Category: Article
ISSN: 1473-0502
DOI: 10.1016/j.transci.2007.04.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of a Constitutively Active Hypoxia-I

Use of a Constitutively Active Hypoxia-Inducible Factor-1 Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients. Phase I Dose-Escalation Experience

✍ Rajagopalan, S.; Olin, J.; Deitcher, S.; Pieczek, A.; Laird, J.; Grossman, P. M. 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 821 KB

Hypoxia-mediated activation of signal tr

Hypoxia-mediated activation of signal transducer and activator of transcription 3 (STAT3) in ovarian cancer: A novel therapeutic strategy using HO-3867, a STAT3 inhibitor

✍ G. McCann; K. Selvendiran; K. Hideg; D. Cohn; P. Kuppusamy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB